Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Smith Julie Create: Alert

All | News | Filings
Date FiledTypeDescription
06/15/2023 4 Smith Julie (Director) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns: Granted 19,441 options to buy @ $12.46, valued at $242.2k
06/02/2023 4 Smith Julie (Director) has filed a Form 4 on EXELIXIS, INC.
Txns: Granted 44,087 options to buy @ $19.39, valued at $854.8k
06/08/2022 4 Smith Julie (Director) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns: Granted 21,000 options to buy @ $12.96, valued at $272.2k
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/25/2021 4 Smith Julie (Director) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns: Granted 11,650 options to buy @ $40.37, valued at $470.3k
05/28/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/05/2020 4 Smith Julie (Director) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns: Granted 29,555 options to buy @ $26.53, valued at $784.1k
05/22/2020 4 Smith Julie (Director) has filed a Form 4 on EXELIXIS, INC.
Txns: Granted 15,538 shares @ $0
01/15/2020 4 Smith Julie (Director) has filed a Form 4 on Audentes Therapeutics, Inc.
Txns: Disposed/sold 18,000 options to buy @ $17.85, valued at $321.3k
Disposed/sold 9,000 options to buy @ $0
Disposed/sold 10,000 options to buy @ $38.65, valued at $386.5k
Disposed/sold 16,200 options to buy @ $24.74, valued at $400.8k
05/24/2019 4 Smith Julie (Director) has filed a Form 4 on EXELIXIS, INC.
Txns: Granted 42,641 options to buy @ $19.77, valued at $843k
02/08/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2018 4 Smith Julie (Director) has filed a Form 4 on Audentes Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $38.65, valued at $386.5k
05/24/2018 4 Smith Julie (Director) has filed a Form 4 on EXELIXIS, INC.
Txns: Granted 31,167 options to buy @ $20.5, valued at $638.9k
10/10/2017 4 Smith Julie (Director) has filed a Form 4 on Audentes Therapeutics, Inc.
Txns: Granted 9,000 options to buy @ $26.01, valued at $234.1k
05/26/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/24/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/05/2017 4 Smith Julie (Director) has filed a Form 4 on Audentes Therapeutics, Inc.
10/26/2016 4 Smith Julie (President and CEO) has filed a Form 4 on Raptor Pharmaceutical Corp
Txns: Unknown transaction of 45,759 shares @ $9, valued at $411.8k
Disposed/sold 64,179 shares @ $9, valued at $577.6k
Disposed/sold 152,050 options to buy @ $5.27, valued at $801.3k
Disposed/sold 175,000 options to buy @ $8.13, valued at $1.4M
Disposed/sold 240,595 options to buy @ $3.74, valued at $899.8k
09/26/2016 4 Smith Julie (Director) has filed a Form 4 on EXELIXIS, INC.
Txns: Granted 763 shares @ $0
Granted 26,000 options to buy @ $14.74, valued at $383.2k
02/11/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
09/12/2012 4 Smith Julie (EVP, Strategy and COO) has filed a Form 4 on Raptor Pharmaceutical Corp
Txns: Granted 190,000 options to buy @ $5.27, valued at $1M

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy